MFS
VIVO

MSI Financial Services’s Meridian Bioscience Inc VIVO Stock Holding History

MSI Financial Services’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5
Closed – – 4067
2016
Q3 		$0 Buy
+5
New +$98 ﹤0.01% 4090

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

MSI Financial Services's VIVO Position: Q4 2016 in Review

MSI Financial Services sold out of Meridian Bioscience Inc (VIVO) in Q4 2016, closing a stake of 5 shares.

MSI Financial Services first reported a position in VIVO in Q3 2016 and held it in 1 quarter. The position peaked at $0 in Q3 2016. 180 funds tracked by Wall St. Rank hold VIVO as of Q4 2016.

  • MSI Financial Services reported no remaining Meridian Bioscience Inc position as of Q4 2016 after selling out during the quarter.
  • MSI Financial Services sold 5 Meridian Bioscience Inc shares in Q4 2016.
  • MSI Financial Services first reported a position in Meridian Bioscience Inc in Q3 2016 and held it in 1 quarter.
  • MSI Financial Services's Meridian Bioscience Inc position peaked at $0 in Q3 2016.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.